Ensuring reliability of clinical assessments for SLE trials
- PMID: 10568905
- DOI: 10.1191/096120399680411353
Ensuring reliability of clinical assessments for SLE trials
Abstract
Conducting clinical trials in lupus presents unique challenges for the investigator. Since reliable data are crucial for precisely evaluating results, strategies must be in place to ensure that outcome assessments are accurate and consistent throughout a study. This paper reviews reliability in clinical research and specifically with lupus outcome measures. Suggested recommendations for ensuring reliability in lupus trials are provided.
Similar articles
-
Quality of life and economic evaluation in SLE clinical trials.Lupus. 1999;8(8):645-54. doi: 10.1191/096120399680411344. Lupus. 1999. PMID: 10568902
-
Outcome measures to be used in clinical trials in systemic lupus erythematosus.J Rheumatol. 1999 Feb;26(2):490-7. J Rheumatol. 1999. PMID: 9972993
-
Classification and definition of major flares in SLE clinical trials.Lupus. 1999;8(8):685-91. doi: 10.1191/096120399680411281. Lupus. 1999. PMID: 10568907
-
Measuring disease activity in systemic lupus: progress and problems.J Rheumatol. 2002 Nov;29(11):2256-7. J Rheumatol. 2002. PMID: 12415577 Review. No abstract available.
-
Endpoints: consensus recommendations from OMERACT IV. Outcome Measures in Rheumatology.Lupus. 2000;9(5):322-7. doi: 10.1191/096120300678828424. Lupus. 2000. PMID: 10878722 Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical